The MED23 gene plays a significant role in human development, and mutations in this gene have been associated with mental retardation autosomal recessive type 18, a condition characterized by intellectual disabilities and potentially other neurological or physical abnormalities. The genetic test for this condition is designed to identify mutations in the MED23 gene to confirm a diagnosis, which can help in the management and understanding of the condition.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, this specific test provides a crucial diagnostic tool for families and individuals at risk. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it offers into the MED23 gene's role in mental retardation autosomal recessive type 18. By opting for this test, patients and healthcare providers can make informed decisions regarding care plans and potential interventions, enhancing the quality of life for those affected by the condition.
The CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CRBN gene. These mutations are associated with a rare form of intellectual disability, known as Autosomal Recessive Mental Retardation Type 2. This condition is characterized by significant cognitive, social, and developmental delays, and it is inherited in an autosomal recessive pattern, meaning that an affected individual receives a defective gene from each parent.
The test is conducted through a comprehensive analysis of the patient's DNA, specifically targeting the CRBN gene to detect any anomalies or mutations that may be responsible for the condition. This genetic test is crucial for early diagnosis and management of the disorder, allowing for tailored therapeutic interventions and support to improve the quality of life for affected individuals and their families.
The cost of the CRBN Gene Mental Retardation Autosomal Recessive Type 2 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the CRBN gene and provide reliable results. Early detection through this test can be a critical step in managing the condition effectively, offering insights into potential treatments and supportive measures.
The LINS1 Gene Mental Retardation Autosomal Recessive Type 27 Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the LINS1 gene. These mutations are associated with a rare condition known as Mental Retardation, Autosomal Recessive Type 27, a disorder that affects intellectual development and may cause other physical and neurological issues. The test is crucial for early diagnosis, enabling appropriate interventions and support for affected individuals and their families. Conducted in a state-of-the-art facility, the test involves analyzing the patient's DNA sample to identify any genetic abnormalities in the LINS1 gene. Priced at 4400 AED, this genetic test is a valuable tool for healthcare professionals and families seeking to understand and manage the implications of this autosomal recessive condition.
The "CC2D1A Gene Mental Retardation Autosomal Recessive Type 3 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the CC2D1A gene. This gene has been associated with a form of mental retardation known as Autosomal Recessive Type 3. Mental retardation, now more commonly referred to as intellectual disability, is characterized by below-average intellectual function and a lack of skills necessary for daily living. The condition linked to the CC2D1A gene affects cognitive development and can present various degrees of intellectual disability from mild to severe.
The test is particularly important for families with a history of this condition, offering them a chance to understand their genetic status and make informed decisions regarding family planning. It can also provide essential information for the management and support of individuals with the condition, allowing for tailored educational and developmental interventions.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab. The sample is then analyzed for specific mutations in the CC2D1A gene that are known to cause Autosomal Recessive Type 3 mental retardation.
The cost of the test is 4400 AED, which reflects the specialized nature of the genetic analysis and the profound impact the results can have on individuals and families. While the cost may be significant, the value of the information gained can be invaluable for affected families, providing a clear genetic diagnosis and guiding future decisions regarding health and family planning.
The ADAT3 Gene Mental Retardation Autosomal Recessive Type 36 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the ADAT3 gene, which are linked to a rare form of autosomal recessive intellectual disability. This condition, known as Mental Retardation, Autosomal Recessive Type 36, is characterized by developmental delays, intellectual challenges, and possibly other neurological or physical symptoms. The test is crucial for families seeking a definitive diagnosis to understand the genetic underpinnings of intellectual disabilities within their family, potentially guiding treatment and support options.
Conducted at DNA Labs UAE, a facility known for its advanced genetic testing services, the test requires a DNA sample, typically obtained through a blood draw. The process involves analyzing the genetic material for specific mutations in the ADAT3 gene that are responsible for this condition. The outcome of this test not only aids in confirming a diagnosis but also helps in genetic counseling, where families can understand the risk of recurrence in future pregnancies.
The cost of the ADAT3 Gene Mental Retardation Autosomal Recessive Type 36 Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the genetic analysis, including the sophisticated technology and expertise required to accurately identify mutations in the ADAT3 gene. For families and individuals undergoing this test, the results can provide invaluable insights into their condition, offering a pathway towards more tailored and effective management strategies.
The ANK3 gene mental retardation autosomal recessive type 37 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the ANK3 gene, which are associated with a specific form of intellectual disability known as autosomal recessive type 37. This condition is characterized by developmental delays, cognitive impairments, and in some cases, physical abnormalities. The test is crucial for families seeking a definitive diagnosis of this rare genetic disorder, enabling them to make informed decisions about care and management.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic markers indicative of the condition. With a cost of 4400 AED, the test represents a significant investment for families. However, it offers invaluable insights into the genetic underpinnings of the disorder, paving the way for targeted interventions and support. DNA Labs UAE is known for its accuracy, confidentiality, and the comprehensive support it offers to patients and families navigating the complexities of genetic disorders.
The HERC2 Gene Mental Retardation Autosomal Recessive Type 38 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the HERC2 gene. These mutations are known to cause a rare form of intellectual disability known as Autosomal Recessive Type 38. The test is crucial for individuals suspected of having this condition or for families seeking genetic counseling due to a history of the disorder. By analyzing the genetic makeup of an individual, this test can confirm the presence of the specific mutations in the HERC2 gene that lead to the disorder, thereby facilitating early intervention, management, and support for affected individuals. The test is priced at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided by DNA Labs UAE to assist in the accurate diagnosis and understanding of this condition.
The TTI2 Gene Mental Retardation Autosomal Recessive Type 39 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the TTI2 gene, which are linked to a specific form of intellectual disability known as Autosomal Recessive Type 39. This condition is characterized by developmental delays, cognitive impairments, and possibly other physical and neurological abnormalities. The test is crucial for families seeking to understand the genetic underpinnings of intellectual disabilities and is instrumental in guiding clinical management, interventions, and genetic counseling.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the patient's DNA to identify mutations in the TTI2 gene. This comprehensive analysis helps in confirming the diagnosis of Autosomal Recessive Type 39 Mental Retardation, thereby facilitating appropriate care and support for affected individuals. The test is priced at 4400 AED, reflecting the intricate technology and expertise required to accurately detect and interpret genetic variations associated with this condition.
The ARID1B Gene Mental Retardation Autosomal Dominant Type 12 Genetic Test is a specialized diagnostic tool designed to identify mutations in the ARID1B gene, which are linked to a form of intellectual disability known as Autosomal Dominant Mental Retardation Type 12. This condition is characterized by developmental delays, intellectual challenges, and in some cases, physical abnormalities. The ARID1B gene plays a critical role in chromatin remodeling, which is essential for DNA repair, replication, and gene expression.
The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the ARID1B gene. This genetic test is crucial for families seeking a diagnosis for intellectual disability, as it can provide definitive answers and help guide treatment and management strategies.
Conducted at DNA Labs UAE, the test is available for a cost of 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals specialized in genetic testing, ensuring accurate and reliable results. The test is recommended for individuals with clinical symptoms of Autosomal Dominant Mental Retardation Type 12 or for families with a history of the condition, aiming to provide them with crucial information for managing the condition effectively.
The DYNC1H1 gene plays a crucial role in the development and function of the nervous system. Mutations in this gene are associated with Mental Retardation Autosomal Dominant Type 13 (MRD13), a condition characterized by intellectual disabilities and, in some cases, neurological and muscular impairments. The genetic test for MRD13 focuses on identifying mutations in the DYNC1H1 gene to confirm a diagnosis, guide treatment options, and offer genetic counseling.
At DNA Labs UAE, individuals can undergo the DYNC1H1 Gene Mental Retardation Autosomal Dominant Type 13 Genetic Test. This test is meticulously designed to detect the specific genetic alterations within the DYNC1H1 gene that are linked to the condition. With a cost of 4400 AED, the test provides a valuable resource for families seeking answers about MRD13, enabling them to make informed decisions about their health and care. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for the presence of mutations in the DYNC1H1 gene. Results from this test can offer crucial insights into the condition, facilitating personalized treatment plans and supporting early intervention strategies.
